Pharmafile Logo
Pharmafocus logo
Advanced Search

Allergan

Showing 15 posts of 142 posts found.

Allergan image

Allergan slashes 1,500 jobs

July 22, 2014
Research and Development, Sales and Marketing Allergan, Botox, Jobs, cuts, valiant

Allergan is to cut 1,500 jobs as part of a restructure which it believes will make pre-tax savings of around …

News
Valeant image

Valeant goes hostile over Allergan hunt

June 19, 2014
Sales and Marketing Allergan, Botox, Valeant, hostile, takeover

Valeant Pharmaceuticals has turned hostile in its bid to acquire Botox maker Allergan by employing strong-arm tactics in an attempt …

News
Allergan image

Allergan rejects Valeant – again

June 11, 2014
Research and Development, Sales and Marketing Allergan, Botox, Valeant, pershing, pharma

Allergan and Valeant Pharmaceuticals International are continuing their stately dance around one another – and in the latest move the …

News
Allergan image

Valeant ‘substantially undervalues’ Allergan

May 13, 2014
Sales and Marketing Allergan, Botox, Pfizer, Valeant, buyout, merger

Allergan’s board has issued a defiant, unanimous rejection of the multi-billion dollar takeover offer made public by Valeant last month. In …

News
Allergan image

Valeant makes $45.7 billion Allergan offer

April 23, 2014
Sales and Marketing Allergan, Botox, GSK, Novartis, Pfizer, Valeant, merger, pershing

In the latest proposal in a flurry of merger and acquisition activity in the pharma sector, Valeant Pharmaceuticals International wants …

News
Allergan image

Allergan reprimanded over Botox promotion

March 19, 2014
Medical Communications, Sales and Marketing ABPI, Allergan, Botox, Galderma, PMCPA, vistabel

Allergan has been found guilty of breaching six clauses of the ABPI’s Code of Practice over its market research for …

News
douglas_ingram_allergan

Allergan announces new president

June 26, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, ingram

Allergan has hired Douglas Ingram to be its president and lead the company’s global commercial operations. In this newly established …

Appointment

Allergan in $958m neurology deal

January 25, 2013
Sales and Marketing Allergan, CNS, MAP Pharmaceuticals, migraine

Allergan is to pay $958m for MAP Pharmaceuticals in a deal which sees both companies hoping to reap the benefits …

News
Allergan image

Botox US bladder indication

January 22, 2013
Sales and Marketing Allergan, Botox, FDA, bladder

Allergan’s Botox has been given approval by the FDA for the treatment of overactive bladder (OAB) in adults.Botox (onabotulinumtoxinA) has …

News

Allergan signs $1.5 billion deal with Molecular Partners

August 22, 2012
Research and Development, Sales and Marketing Allergan, Molecular Partners, eye diseases

Allergan has signed a deal potentially worth $1.5 billion with Molecular Partners to develop new drugs for certain eye diseases. …

News
NICE image

NICE changes its mind on Botox

May 11, 2012
Sales and Marketing Allergan, Botox, NHS, NICE

NICE is now recommending Allergan’s Botox for chronic migraines, reversing its previous decision.  The watchdog said in final draft guidance …

News

NICE frowns on Botox for headache prevention

February 16, 2012
Sales and Marketing Allergan, Botox, EMA, NHS, NICE

NICE is not recommending Allergan’s Botox for headache prevention, and has asked the firm for more information on the drug.  …

News
Twitter logo

Watchdog frowns on Botox tweet

February 15, 2012
Medical Communications Allergan, Chugai, PMCPA, Twitter

Allergan have been found in breach of the UK Code of Practice after an employee used Twitter to communicate about …

News

Allergan plans $350m expansion of Irish plant

January 10, 2012
Manufacturing and Production Allergan, Ireland

Allergan has announced plans to invest $350 million in an expansion of its manufacturing facility in County Mayo, Ireland, a …

News

FDA approves Botox to treat urinary incontinence

August 25, 2011
Sales and Marketing Allergan, Botox, urinary incontinence

Botox has been approved in the US to treat urinary incontinence as manufacturer Allergan continues to expand the brand’s non-cosmetic …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025